Akron has a strategic focus on the discovery, development and manufacturing of innovative tools and technologies, and providing services for the regenerative medicine industry. As a compliant global manufacturer, Akron develops and supplies innovative solutions to key problems in the tissue engineering, cell and gene therapy industry. These include cGMP growth factors, culture media, recombinant and human proteins, novel cryopreservation media, delivery technologies and bioengineered scaffolds for discovery, development, and commercialization. Our company’s unique business model emphasizes flexibility, quality, and unparalleled service—from research and development through clinical trial, market authorization, and commercial product.
Location: United States, Florida, Boca Raton
Phone: +1 561-750-6120
Founded date: 2006
Investors 2
| Date | Name | Website |
| - | BroadOak C... | broadoak.c... |
| - | Arcline In... | arcline.co... |
Mentions in press and media 4
| Date | Title | Description |
| 28.10.2022 | Meeting the Increasing Manufacturing Demands of the Rapidly Growing Cell and Gene Therapy and Vaccine Markets, Upcoming Webinar Hosted by Xtalks | The speakers will discuss the cGMP quality controls and the full suite of pDNA-centered, in-house analytical development, qualification, and validation capabilities. TORONTO, Ontario (PRWEB) October 28, 2022 Join this webinar to discuss the... |
| 28.07.2022 | Natural Killer Cells: Progress and Promise, Upcoming Webinar Hosted by Xtalks | How are these new technologies enabling commercial readiness and creating meaningful opportunities to elevate the standard of care in solid tumor indications? TORONTO (PRWEB) July 28, 2022 Natural killer (NK) cells have moved front and cent... |
| 12.07.2021 | All that Glitters is not Gold – A Discussion on the Stark Differences in “cGMP” Plasmid Manufacturing, Quality, and Regulations, Upcoming Webinar Hosted by Xtalks | Register for the webinar and be armed with critical information needed for your next plasmid DNA outsourcing decision. TORONTO (PRWEB) July 12, 2021 During this webinar, an expert panel will discuss how and why plasmid DNA manufactured unde... |
| 24.02.2021 | De-risking the Manufacturing of Cell Therapies through Virus-Inactivated Products, Upcoming Webinar Hosted by Xtalks | As advanced therapies progress through the clinical pipeline, the integrity of the materials used during manufacture becomes increasingly critical. TORONTO (PRWEB) February 24, 2021 As advanced therapy developers approach approval and comme... |